ANTIOXIDANT ACTIVITY;
BREAST CANCER;
CANCER RADIOTHERAPY;
CELL PROTECTION;
CONTROLLED STUDY;
EDITORIAL;
FIBROSIS;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
PHYTOCHEMISTRY;
PRIORITY JOURNAL;
RADIATION SICKNESS;
RECURRENT CANCER;
RISK ASSESSMENT;
Randomized trial of antioxidant vitamins to prevent acute adverse events of head and neck cancer in head and neck cancer patients
Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse events of head and neck cancer in head and neck cancer patients. J Clin Oncol. 2005;23:5805-5813.
Implications for tumor control during protection of normal tissues with antioxidants
Camphausen K, Citrin D, Krishna MC, Mitchell JB. Implications for tumor control during protection of normal tissues with antioxidants. J Clin Oncol. 2005;23:5455-5457.
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial
Shin DM, Khuri FR, Murphy B, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol. 2001;19:3010-3017.
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Lissoni P, Meregalli S, Nosetto L, et al. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology. 1996;53:43-46.
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604-13609.
Orthomolecular oncology review: Ascorbic acid and cancer 25 years later
Gonzalez MJ, Miranda-Massari JR, Mora EM, et al. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32-44.